Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry

Am J Hematol. 2019 Jan;94(1):E37-E41. doi: 10.1002/ajh.25334. Epub 2018 Nov 25.

¹ Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
² French Reference Center for Aplastic Anemia and PNH, Hôpital Saint-Louis AP-HP, Paris, France.
³ Université Paris Diderot, Paris, France.
⁴ Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
⁵ Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea.
⁶ Department of Haematology, Leeds Teaching Hospitals, Leeds, United Kingdom.
⁷ Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
⁸ Institute of Transfusion Medicine, University of Ulm and Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm, Ulm, Germany.
⁹ Alexion Pharmaceuticals, Inc., Boston, Massachusetts.
¹⁰ Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.

No abstract available

Publication types